Dabigatran or Rivaroxaban Versus Other Anticoagulants for Thromboprophylaxis After Major Orthopedic Surgery: Systematic Review of Comparative Clinical-Effectiveness and Safety

Lignende værker

• The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery
  af: Rachidi, Saleh, et al.
  Udgivet: (2013)
• Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux
  af: DI BENEDETTO, PAOLO, et al.
  Udgivet: (2017)
• Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions
  af: Kreutz, Reinhold, et al.
  Udgivet: (2016)
• Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants
  af: Perka, Carsten
  Udgivet: (2011)
• Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery
  af: Kuroda Y, et al.
  Udgivet: (2013-10-01)